ORTINGLOBE

ORTIN GLOBAL LIMITED (ORTINGLOBE) Stock Analysis

Ortin Global Limited is a pharmaceutical company engaged in formulations and drug distribution in India. It markets generic medicines and healthcare products through trade channels. The business focuses on affordable pharma supply. It is listed on Indian stock exchanges.

Healthcare › Drug Manufacturers - Specialty & Generic

₹15.60

-8.48% 1W | +31.90% 52W

Market Cap

13 CR

P/E Ratio

–

52W High

₹21.3

52W Low

₹10.7

Div. Yield

Beta

0.5

50 DMA

₹15.5

200 DMA

₹15.3

Profit Margin

Inst. Own.

⚡ APPROACHING SUPPORT

Fundamentals

Profit & Loss

Metric	Jun 2011	Mar 2012	Jun 2012
Sales	19.81	19.77	15.93
Expenses	17.13	20.77	13.85
Operating Profit	2.68	-1.00	2.08
OPM %	13.53%	-5.06%	13.06%
Other Income	0.01	0.19	0.03
Interest	0.55	0.98	1.12
Depreciation	0.34	0.39	0.33
Profit before tax	1.80	-2.18	0.66
Tax %	33.33%	-11.93%	33.33%
Net Profit	1.20	-1.92	0.44
EPS in Rs	3.24	-1.14	0.26

Shareholding Pattern

Period

Promoters1.23%

FIIs1.80%

Public96.96%

ORTINGLOBE

Holdings Analysis

Key strengths & risk signals

Overall

Fundamental

Technical

Risks (2)

LOW MARGIN! 0% profit margin - thin profits.

NEGATIVE MOMENTUM! Price declined across timeframes - down 8.5% (1 week), 1.6% (1 month), 9.3% (3 months).

Strengths (3)

BULLISH TREND! 50-day average (15.5) is above 200-day average (15.3) - positive signal.

GOOD YEAR! Stock gained 31.9% in the last year.

BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 25,537 vs down days: 8,987. Ratio: 2.84x

Fundamental & Technical Analysis

52Overall

24Fundamental

80Technical

Fundamental Breakdown

Growth Quality

4/30

Revenue CAGR: -74.4% (DECLINING, 2/15). Profit CAGR: 0% (DECLINING, 2/15).

Profit Margin

0/10

LOW MARGIN! 0% profit margin - thin profits.

PEG Valuation

0/10

Cannot calculate PEG - insufficient growth data.

Dividend Yield

3/10

NEGLIGIBLE DIVIDEND! 0% yield - little to no income.

Debt to Equity

10/10

VERY LOW DEBT! D/E of 0.00 - excellent financial health.

Public Holding

5/20

TOO MUCH PUBLIC HOLDING! 92.63% public ownership - higher volatility risk.

Stability Index

2/10

CAUTION! Company made loss in last quarter. Be careful.

Technical Breakdown

Moving Averages

10/10

BULLISH TREND! 50-day average (15.5) is above 200-day average (15.3) - positive signal.

Price Position

8/10

STRONG POSITION! Current price (15.6) is above both moving averages.

Trend Pattern

10/20

TESTING SUPPORT! Stock is at key support level.

52W Performance

10/10

GOOD YEAR! Stock gained 31.9% in the last year.

Volume Sentiment

30/30

BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 25,537 vs down days: 8,987. Ratio: 2.84x

RSI

3/5

NEUTRAL! RSI at 48.3 - balanced momentum.

52W Range

3/5

MID RANGE! Trading at 46.2% of 52W range - neutral zone.

Momentum

1/5

NEGATIVE MOMENTUM! Price declined across timeframes - down 8.5% (1 week), 1.6% (1 month), 9.3% (3 months).

Beta

5/5

LOW VOLATILITY! Beta of 0.50 - stable stock, less market risk.

Peer Comparison

Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks

Industry peers

Stock	Price	P/E	Profit Margin	Revenue CAGR 5Y	Profit CAGR 5Y	52W Change	Stock Strength	Trendline	YoY Profit	QoQ Profit	YoY Revenue	QoQ Revenue
ORTINGLOBE	₹15.60	–	–	-74.4%	–	+31.9%	52	APPROACHING SUPPORT	+50.0%	–	–	–
LASA	₹5.90	–	-253.8%	-42.1%	–	-50.5%	40	BREAKDOWN	-82.9%	-14.3%	-94.0%	-1,300.0%
VIVIMEDLAB	₹5.50	–	-231.3%	-27.9%	–	+12.7%	42	BREAKDOWN	+2,526.8%	+786.1%	-53.1%	-25.0%
MANGALAM	₹32.60	–	-16.5%	-14.3%	–	-54.4%	44	CONSOLIDATION	-44.9%	-43.3%	-0.2%	-15.2%
BIOFILCHEM	₹32.60	108.7	1.4%	-1.9%	70.7%	-23.4%	54	HIT RESISTANCE	-95.8%	-50.0%	+93.8%	+63.2%
VAISHALI	₹8.20	–	4.1%	18.0%	-15.2%	-27.4%	57	CONSOLIDATION	–	+278.0%	–	-15.0%
KREBSBIO	₹56.00	–	-55.9%	-23.1%	–	-28.3%	49	CONSOLIDATION	-52.8%	+8.7%	+27.3%	+2.9%
ALPA	₹59.50	29.2	3.8%	4.3%	6.1%	-37.0%	46	APPROACHING SUPPORT	-91.5%	-28.6%	+25.1%	-23.9%

Data from TradeAlone · Updated daily

No news tagged for ORTINGLOBE yet.